Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-03

Clinical Trial Update: Autologous Cell Therapy for Female Stress Urinary Incontinence [Phase 2]

View source ↗

Summary

Phase 2 trial update for autologous cell therapy in female stress urinary incontinence; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cook MyoSite autologous cell therapy for stress urinary incontinence

Snippet

Sponsor: Cook MyoSite | Conditions: Stress Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2015-11-03